Gout Highlights
- Abstract 518: Placebo-Controlled Pilot Study of Rilonacept (IL-1 Trap), A Long Acting IL-1 Inhibitor, In Refractory Chronic Active Gouty Arthritis
- Abstract 755: Mouse IL-1 Trap Reduces Pain and Inflammation in Animal Models of Gout
- Abstract 757: Urate-Lowering Therapy (Febuxostat [FEB] or Allopurinol [ALLO]) in Subjects with Gout: Interim Results from the Febuxostat Comparative Extension Long-Term Study (EXCEL)
- Abstract 758: Gout Flare Incidence in Relation to Average Serum Urate during the First Year of Urate-Lowering Therapy
- Abstract #756 Disordered Osteoclast Development in Patients with Tophaceous Gout; Uric Acid Crystals Promote Osteoclastogenesis Through Interactions with Stromal Cells
